These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 31211644)
1. Knowledge of Fentanyl and Perceived Risk of Overdose Among Persons Who Use Drugs in Vancouver, Canada. Moallef S; Nosova E; Milloy MJ; DeBeck K; Fairbairn N; Wood E; Kerr T; Hayashi K Public Health Rep; 2019; 134(4):423-431. PubMed ID: 31211644 [TBL] [Abstract][Full Text] [Related]
2. Changes in drug use behaviors coinciding with the emergence of illicit fentanyl among people who use drugs in Vancouver, Canada. Brar R; Grant C; DeBeck K; Milloy MJ; Fairbairn N; Wood E; Kerr T; Hayashi K Am J Drug Alcohol Abuse; 2020 Sep; 46(5):625-631. PubMed ID: 32689810 [No Abstract] [Full Text] [Related]
3. Effect of witnessing an overdose on the use of drug checking services among people who use illicit drugs in Vancouver, Canada. Beaulieu T; Hayashi K; Nosova E; Milloy MJ; DeBeck K; Wood E; Kerr T; Ti L Am J Drug Alcohol Abuse; 2020 Jul; 46(4):506-511. PubMed ID: 31983241 [TBL] [Abstract][Full Text] [Related]
4. Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: A cross-sectional urine toxicology screening study. Hayashi K; Milloy MJ; Lysyshyn M; DeBeck K; Nosova E; Wood E; Kerr T Drug Alcohol Depend; 2018 Feb; 183():1-6. PubMed ID: 29220642 [TBL] [Abstract][Full Text] [Related]
5. Awareness, Possession, and Use of Take-Home Naloxone Among Illicit Drug Users, Vancouver, British Columbia, 2014-2015. Nolan S; Buxton J; Dobrer S; Dong H; Hayashi K; Milloy MJ; Kerr T; Montaner J; Wood E Public Health Rep; 2017; 132(5):563-569. PubMed ID: 28750193 [TBL] [Abstract][Full Text] [Related]
6. High Prevalence of Self-Reported Exposure to Adulterated Drugs Among People Who Experienced an Opioid Overdose in Canada: A Cohort Study. Prangnell A; Fairgrieve C; Nosova E; DeBeck K; Milloy MJ; Hayashi K Subst Use Misuse; 2019; 54(6):980-985. PubMed ID: 30663484 [TBL] [Abstract][Full Text] [Related]
7. Being "hooked up" during a sharp increase in the availability of illicitly manufactured fentanyl: Adaptations of drug using practices among people who use drugs (PWUD) in New York City. McKnight C; Des Jarlais DC Int J Drug Policy; 2018 Oct; 60():82-88. PubMed ID: 30176422 [TBL] [Abstract][Full Text] [Related]
8. Elevated prevalence of self-reported unintentional exposure to fentanyl among women who use drugs in a Canadian setting: A cross-sectional analysis. Mitra S; Boyd J; Wood E; Grant C; Milloy MJ; DeBeck K; Kerr T; Hayashi K Int J Drug Policy; 2020 Sep; 83():102864. PubMed ID: 32702611 [TBL] [Abstract][Full Text] [Related]
9. Perceptions about fentanyl-adulterated heroin and overdose risk reduction behaviors among persons seeking treatment for heroin use. Stein MD; Kenney SR; Anderson BJ; Bailey GL J Subst Abuse Treat; 2019 Sep; 104():144-147. PubMed ID: 31370978 [TBL] [Abstract][Full Text] [Related]
10. Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence. Sherman SG; Morales KB; Park JN; McKenzie M; Marshall BDL; Green TC Int J Drug Policy; 2019 Jun; 68():46-53. PubMed ID: 30991301 [TBL] [Abstract][Full Text] [Related]
11. Awareness of fentanyl exposure and the associated overdose risks among people who inject drugs in a Canadian setting. Hayashi K; Wood E; Dong H; Buxton JA; Fairbairn N; DeBeck K; Milloy MJ; Kerr T Drug Alcohol Rev; 2021 Sep; 40(6):964-973. PubMed ID: 33604968 [TBL] [Abstract][Full Text] [Related]
12. Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence. Rouhani S; Park JN; Morales KB; Green TC; Sherman SG Harm Reduct J; 2019 Jun; 16(1):39. PubMed ID: 31234942 [TBL] [Abstract][Full Text] [Related]
13. Factors Associated with Nonfatal Overdose During a Public Health Emergency. Wallace B; Kennedy MC; Kerr T; Pauly B Subst Use Misuse; 2019; 54(1):39-45. PubMed ID: 30362861 [TBL] [Abstract][Full Text] [Related]
14. Preferred pharmaceutical-grade opioids to reduce the use of unregulated opioids: A cross-sectional analysis among people who use unregulated opioids in Vancouver, Canada. Speed KA; Choi J; Felicella G; Sedgemore KO; Mok WY; Milloy MJ; DeBeck K; Kerr T; Hayashi K Int J Drug Policy; 2024 Oct; 132():104564. PubMed ID: 39236550 [TBL] [Abstract][Full Text] [Related]
15. Preference for drugs containing fentanyl from a cross-sectional survey of people who use illicit opioids in three United States cities. Morales KB; Park JN; Glick JL; Rouhani S; Green TC; Sherman SG Drug Alcohol Depend; 2019 Nov; 204():107547. PubMed ID: 31536877 [TBL] [Abstract][Full Text] [Related]
16. Temporal changes in non-fatal opioid overdose patterns among people who use drugs in a Canadian setting. Fairgrieve C; Nosova E; Milloy MJ; Fairbairn N; DeBeck K; Ahamad K; Wood E; Kerr T; Hayashi K Subst Abus; 2020; 41(3):323-330. PubMed ID: 32348197 [No Abstract] [Full Text] [Related]
17. Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States. Peiper NC; Clarke SD; Vincent LB; Ciccarone D; Kral AH; Zibbell JE Int J Drug Policy; 2019 Jan; 63():122-128. PubMed ID: 30292493 [TBL] [Abstract][Full Text] [Related]
18. Correlates of fentanyl preference among people who use drugs in Rhode Island. Napoleon SC; Park CJ; Goldman J; Li Y; Buxton JA; Macmadu A; Biello KB; Noguchi J; Marshall BDL Harm Reduct J; 2024 Sep; 21(1):169. PubMed ID: 39272059 [TBL] [Abstract][Full Text] [Related]
19. Prevalence and longitudinal correlates of recent exposure to fentanyl among HIV-positive people who use unregulated drugs during a community-wide overdose crisis. Moallef S; Nosova E; Nolan S; Fairbairn N; Loh J; Hayashi K; Milloy MJ AIDS Care; 2021 Dec; 33(12):1560-1568. PubMed ID: 33764814 [TBL] [Abstract][Full Text] [Related]
20. Investigating opioid preference to inform safe supply services: A cross sectional study. Ferguson M; Parmar A; Papamihali K; Weng A; Lock K; Buxton JA Int J Drug Policy; 2022 Mar; 101():103574. PubMed ID: 35007878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]